Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type
NCT ID: NCT01119209
Last Updated: 2011-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
74 participants
INTERVENTIONAL
2008-02-29
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture
NCT00529425
Pain Management Following Total Hip Arthroplasty
NCT02568995
Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study
NCT00289419
Use of Local Infiltration Analgesia Following Total Hip Arthroplasty
NCT01344395
Effect of Local Infiltration Analgesia in Total Hip Arthroplasty
NCT00968955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
Ropivacaine
Approved by the Danish Medicines Agency
Saline
Approved by the Danish Medicines Agency
Saline
Saline
Approved by the Danish Medicines Agency
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine
Approved by the Danish Medicines Agency
Saline
Approved by the Danish Medicines Agency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fracture due to low energy trauma
* Ability to understand danish and give informed consent
* Ability to walk before trauma
* Indication for osteosynthesis
•≥ 8 in OMC (Orientation-Memory-Concentration) test with a possible maximum of 28 points
* Informed consent
Exclusion Criteria
* Drug intolerance
* Pathological fractures
* Inflammatory arthritis
* Patient included in the study with the contralateral hip
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Odense University Hospital, DK-5000 Odense C, Denmark
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soren Overgaard, MD, DmSc
Role: STUDY_CHAIR
Odense University Hospital, DK-5000 Odense C, Denmark
Rune Dueholm Bech, MD
Role: PRINCIPAL_INVESTIGATOR
Odense University Hospital, DK-5000 Odense C, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odense University Hospital
Odense, DK, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bech RD, Ovesen O, Lauritsen J, Emmeluth C, Lindholm P, Overgaard S. Local Anesthetic Wound Infiltration after Osteosynthesis of Extracapsular Hip Fracture Does Not Reduce Pain or Opioid Requirements: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial in 49 Patients. Pain Res Manag. 2018 Nov 13;2018:6398424. doi: 10.1155/2018/6398424. eCollection 2018.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-VF-20060072 - trochanteric
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.